Table 2.
Demographic and medical characteristics of respondents (n = 394)
| Characteristic | n (%) |
|---|---|
| Gender | |
| Man | 210 (53) |
| Woman | 184 (47) |
| Age, mean ± SD (range) | 60.4 ± 12.8 (20–84) |
| Marital status | |
| Married or defacto | 280 (71) |
| Single, divorced, separated or widowed | 114 (29) |
| Location | |
| Major city | 198 (50) |
| Regional | 196 (50) |
| Education | |
| Secondary school or below | 71 (18) |
| Trade or other certificate | 127 (32) |
| University degree | 196 (50) |
| Current employment status | |
| Employed | 123 (31) |
| Unemployed | 50 (13) |
| Not in labour force | 221 (56) |
| Dependants living home during COVID-19 | 158 (40) |
| Mean ± SD (range) | 1.65 ± 0.87 (1–5) |
| Years since diagnosis, mean ± SD (range) | 4.32 ± 6.59 (0–62) |
| Primary diagnosis | |
| Leukaemia | 107 (27) |
| Lymphoma | 136 (34) |
| Myeloma | 73 (19) |
| Other haematological cancersa | 78 (20) |
| Years since last treatment, mean ± SD (range) | 2.4 ± 3.5 (0–19) |
| Treatments | |
| Stem cell transplant | 162 (41) |
| Chemotherapy | 314 (80) |
| Radiation therapy | 79 (20) |
| Other treatmentsb | 223 (57) |
| Disease status | |
| Not yet started active treatment | 25 (6) |
| Undergoing curative treatment | 41 (10) |
| Completed treatment and in remission | 146 (37) |
| Ongoing treatment to manage disease | 128 (323) |
| Other | 54 (14) |
| Pre-existing health conditions, mean ± SD (range) | 1.61 ± 1.35 (0–7) |
| High cholesterol | 113 (29) |
| High blood pressure | 129 (33) |
| Diabetes type 1 or 2 | 42 (11) |
| Depression or anxiety | 127 (32) |
| Other | 183 (46) |
aOther haematological cancers include myelodysplastic syndrome, myeloproliferative neoplasms, amyloidosis.
bOther treatments include targeted therapy, immunotherapy, surgery.